{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T17:16:11Z","timestamp":1781543771231,"version":"3.54.5"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2012,5,27]],"date-time":"2012-05-27T00:00:00Z","timestamp":1338076800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2012,8]]},"DOI":"10.1007\/s10067-012-2002-8","type":"journal-article","created":{"date-parts":[[2012,5,26]],"date-time":"2012-05-26T03:13:22Z","timestamp":1338002002000},"page":"1259-1261","source":"Crossref","is-referenced-by-count":8,"title":["Rituximab in a patient with ankylosing spondylitis with demyelinating disease: a case report and review of the literature"],"prefix":"10.1007","volume":"31","author":[{"given":"Mohammed A.","family":"Omair","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khalid A.","family":"Alnaqbi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,5,27]]},"reference":[{"issue":"6","key":"2002_CR1","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1136\/ard.2011.151027","volume":"70","author":"J Braun","year":"2011","unstructured":"Braun J, van den Berg R, Baraliakos X et al (2011) 2010 update of the ASAS\/EULAR recommendations for the management of ankylosing spondylitis. Ann Rheum Dis 70(6):896\u2013904","journal-title":"Ann Rheum Dis"},{"issue":"5 Suppl 35","key":"2002_CR2","first-page":"S134","volume":"22","author":"MD Magnano","year":"2004","unstructured":"Magnano MD, Robinson WH, Genovese MC (2004) Demyelination and inhibition of tumor necrosis factor (TNF). Clin Exp Rheumatol 22(5 Suppl 35):S134\u2013S140","journal-title":"Clin Exp Rheumatol"},{"issue":"2","key":"2002_CR3","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1136\/ard.59.2.135","volume":"59","author":"M Bollow","year":"2000","unstructured":"Bollow M, Fischer T, Reisshauer H et al (2000) Quantitative analyses of sacroiliac biopsies in spondyloarthropathies: T cells and macrophages predominate in early and active sacroiliitis\u2014cellularity correlates with the degree of enhancement detected by magnetic resonance imaging. Ann Rheum Dis 59(2):135\u2013140","journal-title":"Ann Rheum Dis"},{"issue":"9","key":"2002_CR4","doi-asserted-by":"crossref","first-page":"2845","DOI":"10.1002\/art.22060","volume":"54","author":"H Appel","year":"2006","unstructured":"Appel H, Kuhne M, Spiekermann S et al (2006) Immunohistologic analysis of zygapophyseal joints in patients with ankylosing spondylitis. Arthritis Rheum 54(9):2845\u20132851","journal-title":"Arthritis Rheum"},{"issue":"5","key":"2002_CR5","doi-asserted-by":"crossref","first-page":"R143","DOI":"10.1186\/ar2035","volume":"8","author":"H Appel","year":"2006","unstructured":"Appel H, Loddenkemper C, Grozdanovic Z et al (2006) Correlation of histopathological findings and magnetic resonance imaging in the spine of patients with ankylosing spondylitis. Arthritis Res Ther 8(5):R143","journal-title":"Arthritis Res Ther"},{"issue":"11","key":"2002_CR6","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1093\/rheumatology\/ken362","volume":"47","author":"C Rodriguez-Escalera","year":"2008","unstructured":"Rodriguez-Escalera C, Fernandez-Nebro A (2008) The use of rituximab to treat a patient with ankylosing spondylitis and hepatitis B. Rheumatology (Oxford) 47(11):1732\u20131733","journal-title":"Rheumatology (Oxford)"},{"issue":"4","key":"2002_CR7","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.jbspin.2008.01.023","volume":"75","author":"D Wendling","year":"2008","unstructured":"Wendling D, Auge B, Streit G, Toussirot E, Mathieu S (2008) Lack of short-term efficacy of rituximab upon symptoms of ankylosing spondylitis treated for an associated vasculitis. Joint Bone Spine 75(4):510\u2013511","journal-title":"Joint Bone Spine"},{"issue":"3","key":"2002_CR8","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1002\/art.23266","volume":"58","author":"D Baeten","year":"2008","unstructured":"Baeten D, Kruithof E, Breban M, Tak PP (2008) Spondylarthritis in the absence of B lymphocytes. Arthritis Rheum 58(3):730\u2013733","journal-title":"Arthritis Rheum"},{"issue":"2","key":"2002_CR9","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1136\/ard.2008.107102","volume":"69","author":"G Nocturne","year":"2010","unstructured":"Nocturne G, Dougados M, Constantin A et al (2010) Rituximab in the spondyloarthropathies: data of eight patients followed up in the French Autoimmunity and Rituximab (AIR) registry. Ann Rheum Dis 69(2):471\u2013472","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"2002_CR10","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1002\/art.27383","volume":"62","author":"IH Song","year":"2010","unstructured":"Song IH, Heldmann F, Rudwaleit M et al (2010) Different response to rituximab in tumor necrosis factor blocker-naive patients with active ankylosing spondylitis and in patients in whom tumor necrosis factor blockers have failed: a twenty-four-week clinical trial. Arthritis Rheum 62(5):1290\u20131297","journal-title":"Arthritis Rheum"},{"issue":"9","key":"2002_CR11","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.3899\/jrheum.110132","volume":"38","author":"Y Huang","year":"2011","unstructured":"Huang Y, Cheng F, Zhang X, Tang J (2011) Marked reduction of sacroiliac joint inflammation on magnetic resonance imaging in a patient with ankylosing spondylitis after rituximab treatment. J Rheumatol 38(9):2083\u20132084","journal-title":"J Rheumatol"},{"issue":"4","key":"2002_CR12","first-page":"409","volume":"38","author":"JW Prineas","year":"1978","unstructured":"Prineas JW, Wright RG (1978) Macrophages, lymphocytes, and plasma cells in the perivascular compartment in chronic multiple sclerosis. Lab Invest 38(4):409\u2013421","journal-title":"Lab Invest"},{"issue":"2","key":"2002_CR13","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1002\/ana.410100205","volume":"10","author":"JW Prineas","year":"1981","unstructured":"Prineas JW, Graham JS (1981) Multiple sclerosis: capping of surface immunoglobulin G on macrophages engaged in myelin breakdown. Ann Neurol 10(2):149\u2013158","journal-title":"Ann Neurol"},{"issue":"6","key":"2002_CR14","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1001\/archneur.1973.00490240052009","volume":"28","author":"JE Olsson","year":"1973","unstructured":"Olsson JE, Link H (1973) Immunoglobulin abnormalities in multiple sclerosis. Relation to clinical parameters: exacerbations and remissions. Arch Neurol 28(6):392\u2013399","journal-title":"Arch Neurol"},{"issue":"8036","key":"2002_CR15","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/S0140-6736(77)91603-8","volume":"2","author":"MM Esiri","year":"1977","unstructured":"Esiri MM (1977) Immunoglobulin-containing cells in multiple-sclerosis plaques. Lancet 2(8036):478","journal-title":"Lancet"},{"issue":"23","key":"2002_CR16","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1212\/WNL.0b013e3181e24373","volume":"74","author":"RT Naismith","year":"2010","unstructured":"Naismith RT, Piccio L, Lyons JA et al (2010) Rituximab add-on therapy for breakthrough relapsing multiple sclerosis: a 52-week phase II trial. Neurology 74(23):1860\u20131867","journal-title":"Neurology"},{"issue":"3","key":"2002_CR17","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1002\/ana.21363","volume":"63","author":"A Bar-Or","year":"2008","unstructured":"Bar-Or A, Calabresi PA, Arnold D et al (2008) Rituximab in relapsing-remitting multiple sclerosis: a 72-week, open-label, phase I trial. Ann Neurol 63(3):395\u2013400","journal-title":"Ann Neurol"},{"issue":"7","key":"2002_CR18","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1056\/NEJMoa0706383","volume":"358","author":"SL Hauser","year":"2008","unstructured":"Hauser SL, Waubant E, Arnold DL et al (2008) B-cell depletion with rituximab in relapsing-remitting multiple sclerosis. N Engl J Med 358(7):676\u2013688","journal-title":"N Engl J Med"},{"issue":"4","key":"2002_CR19","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1002\/ana.21867","volume":"66","author":"K Hawker","year":"2009","unstructured":"Hawker K, O'Connor P, Freedman MS et al (2009) Rituximab in patients with primary progressive multiple sclerosis: results of a randomized double-blind placebo-controlled multicenter trial. Ann Neurol 66(4):460\u2013471","journal-title":"Ann Neurol"},{"issue":"7","key":"2002_CR20","doi-asserted-by":"crossref","first-page":"607","DOI":"10.2165\/11589390-000000000-00000","volume":"25","author":"PS Rommer","year":"2011","unstructured":"Rommer PS, Patejdl R, Winkelmann A, Benecke R, Zettl UK (2011) Rituximab for secondary progressive multiple sclerosis: a case series. CNS Drugs 25(7):607\u2013613","journal-title":"CNS Drugs"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-012-2002-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10067-012-2002-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-012-2002-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T08:51:55Z","timestamp":1559119915000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10067-012-2002-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,5,27]]},"references-count":20,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2012,8]]}},"alternative-id":["2002"],"URL":"https:\/\/doi.org\/10.1007\/s10067-012-2002-8","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,5,27]]}}}